Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Fasano, Alessio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN; GLUTEN; LARAZOTIDE; PLACEBO;

AUTOIMMUNITY; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME THERAPY; GLUTEN FREE DIET; GRAIN; HUMAN; IMMUNOMODULATION; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; PATHOLOGY;

ANIMALS; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DIET, GLUTEN-FREE; GLUTENS; HUMANS;

EID: 84868699661     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/959061     Document Type: Review

References (42)

1. Bevan S., Popat S., Braegger C. P., Busch A., O'Donoghue D., Falth-Magnusson K., Ferguson A., Godkin A., Hogberg L., Holmes G., Hosie K. B., Howdle P. D., Jenkins H., Jewell D., Johnston S., Kennedy N. P., Kerr G., Kumar P., Logan R. F. A., Love A. H. G., Marsh M., Mulder C. J. J., Sjoberg K., Stenhammer L., Walker-Smith J., Marossy A. M., Houlston R. S., Contribution of the MHC region to the familial risk of coeliac disease. Journal of Medical Genetics 1999 36 9 687 690 2-s2.0-0032854079 (Pubitemid 29433727)
2. Högberg L., Fälth-Magnusson K., Grodzinsky E., Stenhammar L., Familial prevalence of coeliac disease: a twenty-year follow-up study. Scandinavian Journal of Gastroenterology 2003 38 1 61 65 2-s2.0-0037255267 10.1080/00365520310000456 (Pubitemid 36152866)
3. Schuppan D., Current concepts of celiac disease pathogenesis. Gastroenterology 2000 119 1 234 242 2-s2.0-0034235978 (Pubitemid 30452598)
4. Fasano A., Not T., Wang W., Uzzau S., Berti I., Tommasini A., Goldblum S. E., Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. The Lancet 2000 355 9214 1518 1519 2-s2.0-0034728821 (Pubitemid 30237361)
5. Byrne S., Cooper Z., Fairburn C., Weight maintenance and relapse in obesity: a qualitative study. International Journal of Obesity 2003 27 8 955 962 2-s2.0-0042165973 10.1038/sj.ijo.0802305 (Pubitemid 36918618)
6. Catassi C., Fabiani E., Iacono G., D'Agate C., Francavilla R., Biagi F., Volta U., Accomando S., Picarelli A., De Vitis I., Pianelli G., Gesuita R., Carle F., Mandolesi A., Bearzi I., Fasano A., A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. American Journal of Clinical Nutrition 2007 85 1 160 166 2-s2.0-33846095469 (Pubitemid 46067630)
7. Accomando S., Picarelli A., DeVitis I., Pianelli G., Gesuita R., Carle F., Mandolesi A., Bearzi I., Fasano A., A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. The American Journal of Clinical Nutrition 2007 85 1 160 166 (Pubitemid 46067630)
8. Lanzini A., Lanzarotto F., Mora A., Bertolazzi S., Benini F., Ricci C., Small intestinal recovery is often incomplete in serum-negative celiacs during gluten free-diet. Gastroenterology 2007 132, article A109
9. Collin P., Thorell L., Kaukinen K., Mäki M., The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Alimentary Pharmacology and Therapeutics 2004 19 12 1277 1283 2-s2.0-3042800754 10.1111/j.1365-2036.2004.01961.x (Pubitemid 38859504)
10. Hischenhuber C., Crevel R., Jarry B., Mäki M., Moneret-Vautrin D. A., Romano A., Troncone R., Ward R., Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Alimentary Pharmacology and Therapeutics 2006 23 5 559 575 2-s2.0-33645007290 10.1111/j.1365-2036.2006. 02768.x
11. Peräaho M., Kaukinen K., Paasikivi K., Sievänen H., Lohiniemi S., Mäki M., Collin P., Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Alimentary Pharmacology and Therapeutics 2003 17 4 587 594 2-s2.0-17144467156 10.1046/j.1365-2036.2003.01425.x (Pubitemid 36384818)
12. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., Londei M., Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. The Lancet 2003 362 9377 30 37 2-s2.0-0038501062 10.1016/S0140-6736(03)13803-2 (Pubitemid 36835817)
13. Madara J. L., Trier J. S., Stuctural abnormalities of jejunal epithelial cell membranes in celiac sprue. Laboratory Investigation 1980 43 3 254 261 2-s2.0-0018909566 (Pubitemid 10061705)
14. Schulzke J. D., Bentzel C. J., Schulzke I., Riecken E. O., Fromm M., Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatric Research 1998 43 4 I 435 441 2-s2.0-0031944553 (Pubitemid 28157949)
15. Clemente M. G., De Virgiliis S., Kang J. S., Macatagney R., Musu M. P., Di Pierro M. R., Drago S., Congia M., Fasano A., Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003 52 2 218 223 2-s2.0-0037302604 10.1136/gut.52.2.218 (Pubitemid 36115062)
16. Drago S., El Asmar R., Di Pierro M., Clemente M. G., Tripathi A., Sapone A., Thakar M., Iacono G., Carroccio A., D'Agate C., Not T., Zampini L., Catassi C., Fasano A., Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian Journal of Gastroenterology 2006 41 4 408 419 2-s2.0-33646426645 10.1080/00365520500235334 (Pubitemid 43675406)
17. Wang W., Uzzau S., Goldblum S. E., Fasano A., Human zonulin, a potential modulator of intestinal tight junctions. Journal of Cell Science 2000 113 24 4435 4440 2-s2.0-0034508690 (Pubitemid 32117904)
18. Tripathi A., Lammers K. M., Goldblum S., Shea-Donohue T., Netzel-Arnett S., Buzza M. S., Antalis T. M., Vogel S. N., Zhao A., Yang S., Arrietta M. C., Meddings J. B., Fasano A., Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences of the United States of America 2009 106 39 16799 16804 2-s2.0-70349736175 10.1073/pnas.0906773106
19. Fasano A., Not T., Wang W., Uzzau S., Berti I., Tommasini A., Goldblum S. E., Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. The Lancet 2000 355 9214 1518 1519 2-s2.0-0034728821 (Pubitemid 30237361)
20. Leach L., Firth J. A., Structure and permeability of human placental microvasculature. Microscopy Research and Technique 1997 38 137 144 (Pubitemid 27328954)
21. Madsen K. L., Lewis S. A., Tavernini M. M., Hibbard J., Fedorak R. N., Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 1997 113 1 151 159 2-s2.0-0031011849 10.1016/S0016-5085(97)70090-8 (Pubitemid 27281769)
22. Schumann M., Günzel D., Buergel N., Richter J. F., Troeger H., May C., Fromm A., Sorgenfrei D., Daum S., Bojarski C., Heyman M., Zeitz M., Fromm M., Schulzke J. D., Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease. Gut 2012 61 220 228
23. Lebreton C., Ménard S., Abed J., Cruz-Moura I., Coppo R., Dugave C., Monteiro R. C., Fricot A., Traore M. G., Cellier C., Malamut G., Cerf-Bensussan N., Heyman M., Interactions among secretory immunogloblulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology 2012 143 3 698 707
24. Arentz-Hansen H., Mcadam S. N., Molberg O., Fleckenstein B., Lundin K. E. A., Jorgensen T. J. D., Jung G., Roepstorff P., Sollid L. M., Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002 123 3 803 809 2-s2.0-0036724918 10.1053/gast.2002.35381 (Pubitemid 34977086)
25. Vader W., Kooy Y., Van Veelen P., De Ru A., Harris D., Benckhuijsen W., Pea S., Mearin L., Drijfhout J. W., Koning F., The Gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002 122 7 1729 1737 2-s2.0-0036082955 (Pubitemid 34651415)
26. Vader L. W., de Ru A., van der Wal Y., Kooy Y. M. C., Benckhuijsen W., Luisa Mearin M., Drijfhout J. W., van Veelen P., Koning F., Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. Journal of Experimental Medicine 2002 195 5 643 649 2-s2.0-0037018095 10.1084/jem.20012028 (Pubitemid 34461509)
27. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G. M., Sollid L. M., Khosla C., Structural basis for gluten intolerance in Celiac Sprue. Science 2002 297 5590 2275 2279 2-s2.0-0037183929 10.1126/science.1074129
28. Qiao S. W., Bergseng E., Molberg O., Xia J., Fleckenstein B., Khosla C., Sollid L. M., Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. Journal of Immunology 2004 173 3 1757 1762 2-s2.0-3242801934 (Pubitemid 38971607)
29. Nilsen E. M., Jahnsen F. L., Lundin K. E. A., Johansen F. E., Fausa O., Sollid L. M., Jahnsen J., Scott H., Brandtzaeg P., Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998 115 3 551 563 2-s2.0-0031660029 (Pubitemid 28397290)
30. Fasano A., Surprise from celiac Disease. Scientific American 2009 301 2 54 61 2-s2.0-68949173750 10.1038/scientificamerican0809-54
31. Aziz I., Evans K. E., Papageorgiou V., Sanders D. S., Are patients with coeliac disease seeking alternative therapies to a gluten-free diet? Journal of Gastrointestinal and Liver Diseases 2011 20 1 27 31 2-s2.0-79953650233
32. Siegel M., Garber M. E., Spencer A. G., Botwick W., Kumar P., Williams R. N., Kozuka K., Shreeniwas R., Pratha V., Adelman D. C., Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Digestive Diseases and Sciences 2012 57 440 450
33. Di Cagno R., De Angelis M., Auricchio S., Greco L., Clarke C., De Vincenzi M., Giovannini C., D'Archivio M., Landolfo F., Parrilli G., Minervini F., Arendt E., Gobbetti M., Sourdough Bread Made from Wheat and Nontoxic Flours and Started with Selected Lactobacilli Is Tolerated in Celiac Sprue Patients. Applied and Environmental Microbiology 2004 70 2 1088 1096 2-s2.0-2342464831 10.1128/AEM.70.2.1088-1096.2004 (Pubitemid 38568235)
34. Piacentini M., Colizzi V., Tissue transglutaminase: apoptosis versus autoimmunity. Immunology Today 1999 20 3 130 134 2-s2.0-0033023517 10.1016/S0167-5699(98)01416-9 (Pubitemid 29130342)
35. Schuppan D., Dieterich W., A molecular warhead and its target: tissue transglutaminase and celiac sprue. Chemistry and Biology 2003 10 3 199 201 2-s2.0-0037350410 10.1016/S1074-5521(03)00055-3 (Pubitemid 36380273)
36. Fasano A., Shea-Donohue T., Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nature Clinical Practice Gastroenterology and Hepatology 2005 2 9 416 422 2-s2.0-27144489109 10.1038/ncpgasthep0259 (Pubitemid 41486094)
37. Ukabam S. O., Cooper B. T., Small intestinal permeability as an indicator of jejunal mucosal recovery in patients with celiac sprue on a gluten-free diet. Journal of Clinical Gastroenterology 1985 7 3 232 236 2-s2.0-0021815675 (Pubitemid 15046283)
38. Watts T., Berti I., Sapone A., Gerarduzzi T., Not T., Zielke R., Fasano A., Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2916 2921 2-s2.0-14544277099 10.1073/pnas.0500178102 (Pubitemid 40299891)
39. Paterson B. M., Lammers K. M., Arrieta M. C., Fasano A., Meddings J. B., The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Alimentary Pharmacology and Therapeutics 2007 26 5 757 766 2-s2.0-34547852241 10.1111/j.1365-2036.2007.03413.x (Pubitemid 47246202)
40. Gopalakrishnan S., Durai M., Kitchens K., Tamiz A. P., Somerville R., Ginski M., Paterson B. M., Murray J. A., Verdu E. F., Alkan S. S., Pandey N. B., Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides 2012 35 86 94
41. Gopalakrishnan S., Tripathi A., Tamiz A. P., Alkan S. S., Pandey N. B., Larazotide acetate promotes tight junction assembly in epithelial cells. Peptides 2012 35 95 101
42. Pérez L. C., de Villasante G. C., Ruiz A. C., León F., Non-dietary therapeutic clinical trials in coeliac disease. European Journal of Internal Medicine 2012 23 9 14